HP
COR icon

HealthInvest Partners’s Cencora COR Stock Holding History

HealthInvest Partners’s Portfolio COR Stock Details COR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.81M Buy
31,126
+7,656
+33% +$2.21M 2.37% 20
2026
Q1 		$6.6M Sell
23,470
-303
-1% -$106K 2.13% 23
2025
Q4 		$8.03M Sell
23,773
-4,835
-17% -$1.65M 2.56% 14
2025
Q3 		$949K Sell
28,608
-2,858
-9% -$841K 3.52% 8
2025
Q2 		$9.44M Sell
31,466
-87
-0.3% -$25.1K 4.04% 10
2025
Q1 		$8.77M Sell
31,553
-1,000
-3% -$251K 3.87% 8
2024
Q4 		$7.31M Sell
32,553
-3,991
-11% -$939K 3.47% 11
2024
Q3 		$8.23M Buy
36,544
+6,224
+21% +$1.44M 3.87% 9
2024
Q2 		$6.83M Buy
30,320
+9,894
+48% +$2.29M 4.17% 9
2024
Q1 		$4.96M Sell
20,426
-18,499
-48% -$4.25M 3.02% 12
2023
Q4 		$7.99M Buy
+38,925
New +$7.6M 6.26% 4
2022
Q4 		$51.2K Buy
+309
New +$48.8K 0.1% 19
2022
Q1 		– Sell
-48,000
Closed -$6.38M – 14
2021
Q4 		$6.38M Buy
48,000
+34,000
+243% +$4.18M 8.99% 6
2021
Q3 		$1.67M Buy
+14,000
New +$1.68M 2.5% 11
2021
Q2 		– Sell
-55,000
Closed -$6.49M – 11
2021
Q1 		$6.49M Sell
55,000
-38,000
-41% -$4.11M 5.17% 10
2020
Q4 		$9.09M Buy
+93,000
New +$9.3M 6.02% 10
2017
Q3 		– Sell
-109,700
Closed -$10.4M – 13
2017
Q2 		$10.4M Sell
109,700
-16,300
-13% -$1.45M 12.93% 3
2017
Q1 		$11.2M Buy
126,000
+19,000
+18% +$1.67M 17.1% 2
2016
Q4 		$8.37M Sell
107,000
-105,000
-50% -$8.19M 7.71% 5
2016
Q3 		$17.1M Buy
212,000
+52,000
+33% +$4.46M 12.74% 2
2016
Q2 		$12.7M Buy
+160,000
New +$12.8M 5.82% 7

Other funds holding COR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HealthInvest Partners's COR Position: Q2 2026 in Review

HealthInvest Partners increased its Cencora (COR) stake by 33% in Q2 2026, buying an estimated $2.21M and bringing the position to 31,126 shares worth $8.81M. The position accounts for 2.37% of the portfolio, ranked #20.

HealthInvest Partners first reported a position in COR in Q2 2016 and has held it in 21 quarters since. The position peaked at $17.1M in Q3 2016. 1,338 funds tracked by Wall St. Rank hold COR as of Q2 2026.

  • HealthInvest Partners held 31,126 shares of Cencora worth $8.81M as of Q2 2026.
  • HealthInvest Partners bought 7,656 Cencora shares in Q2 2026, an estimated $2.21M.
  • Cencora made up 2.37% of HealthInvest Partners's portfolio in Q2 2026, its #20 holding.
  • HealthInvest Partners first reported a position in Cencora in Q2 2016 and has held it in 21 quarters since.
  • HealthInvest Partners's Cencora position peaked at $17.1M in Q3 2016.
  • 1,338 funds tracked by Wall St. Rank held Cencora as of Q2 2026.

Based on HealthInvest Partners's 13F filing for Q2 2026, filed 24 Jul 2026.